Current assessment and management of endoleaks after advanced EVAR: new devices, new endoleaks?
Aortic aneurysm
embolization
endoleak
endovascular aortic aneurysm repair
stent graft
Journal
Expert review of cardiovascular therapy
ISSN: 1744-8344
Titre abrégé: Expert Rev Cardiovasc Ther
Pays: England
ID NLM: 101182328
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
8
7
2020
medline:
14
1
2021
entrez:
8
7
2020
Statut:
ppublish
Résumé
In recent years there has been an increasing application of advanced EVAR techniques to tackle complex clinical and anatomical scenarios. In a bid to overcome the limitations of the traditional stent-grafts, newer EVAR endografts and techniques have been developed and introduced into clinical practice, permitting endovascular management of difficult infrarenal, juxta-renal and thoracoabdominal aneurysms for which previously there was no endovascular solution. As a consequence, we are now confronted with unique patterns of endoleak requiring customized clinical-radiological assessment and treatment. Despite the increasing body of evidence regarding new EVAR techniques and related endoleaks, current guidelines do not specifically address these issues. Our review aims to assess risk factors, development, and management strategies of these endoleaks, in the most recent infrarenal EVAR devices and in more complex fenestrated EVAR (FEVAR) and Chimney EVAR (Ch-EVAR). Most new devices have demonstrated types of endoleaks that need specific imaging and treatment, as in EVAS, FEVAR, and ChEVAR. Knowledge of specific stent-graft characteristics and the nature of endoleaks associated with the various procedures facilitates the application of relevant useful imaging. In addition, it should aid development of a customized and practically relevant approach to patient management during intervention and follow-up.
Identifiants
pubmed: 32634069
doi: 10.1080/14779072.2020.1792294
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM